P-0136 - Oesophageal cancer in Morocco: the epidemiological evidence

Date 28 June 2014
Event World GI 2014
Session Poster Session
Topics Oesophageal Cancer
Cancer Aetiology, Epidemiology, Prevention
Presenter Hinde Hami
Citation Annals of Oncology (2014) 25 (suppl_2): ii14-ii104. 10.1093/annonc/mdu165
Authors A. Ayoujil1, F. Habib2, A. Mokhtari1
  • 1Laboratory of Genetics and Biometry, Faculty of Science, Ibn Tofail University, Kenitra/MA
  • 2Al Azhar Oncology Center, Rabat/MA

Abstract

Introduction

Oesophageal cancer is one of the most serious types of cancer worldwide, owing to its rapid development and fatal prognosis in most cases. In Northern Africa, it is the 18th most commonly diagnosed cancer in men and women and the 13th leading cause of cancer-related death, with an estimated 3 112 new cases of oesophageal cancer and 2 871 cancer deaths in 2012 (GLOBOCAN 2012). This study aims to determine the epidemiological profile of oesophageal cancer in Morocco.

Methods

This is a retrospective analysis of oesophageal cancer cases, diagnosed and treated at Al Azhar Oncology Center in Rabat between 1994 and 2004.

Results

There were 53 people diagnosed with oesophageal cancer at Al Azhar Oncology Center; 33 (62.3%) in men and 20 (37.7%) in women, giving a male-female ratio of 1.65 and accounting for 6.1% of all new cases of gastrointestinal cancer and 0.7% of all cancers reported during the study period. The average age at diagnosis of oesophageal cancer was 63.2 ± 13.9 years. The risk of developing oesophageal cancer is strongly related to age with 16% of new oesophageal cancer cases diagnosed in people younger than 50 years at the time of diagnosis and 84% in those aged 50 years and older. Among all detected cases, 6 (11.3%) were diagnosed with metastatic disease and 16 (30.2%) died during the study period, accounting for 8.2% of all gastrointestinal cancer deaths.

Conclusion

Despite the limitations of the available data, it is clear that there are several barriers to access to cancer control in developing countries. This includes prevention, early detection, diagnosis and treatment.